This heterogeneity in PD-L1 expression was consistent with the results of WANG et al. on 22 patients with CRC with metastasis whose metastatic lesion had higher PD-L1 expression than their primary tumor [28]. The gene discussed is CD274; the disease is colorectal carcinoma.